View Older Stories

Dec 8, 2025 04:02PM Vera Therapeutics plans $200 million stock offering

Dec 5, 2025 04:49AM Vera Therapeutics (VERA) PT Raised to $73 at TD Cowen

Dec 2, 2025 03:50PM Raymond James Reiterates Strong Buy Rating on Vera Therapeutics (VERA)

Nov 28, 2025 06:35AM H.C. Wainwright Reiterates Buy Rating on Vera Therapeutics (VERA)

Nov 26, 2025 07:05AM Vera Therapeutics' (VERA) Shares Are Still Undervalued - Cantor Fitzgerald

Nov 10, 2025 06:48AM Vera Therapeutics (VERA) PT Raised to $90 at H.C. Wainwright

Nov 5, 2025 04:16PM Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 11c

Oct 17, 2025 09:12AM Vera Therapeutics ORIGIN 3 trial to be featured at ASN Kidney Week

Oct 17, 2025 08:00AM Buy this biotech stock ahead of underdog commercial launch

Oct 16, 2025 06:40AM BofA Securities Starts Vera Therapeutics (VERA) at Buy

Oct 13, 2025 07:17AM Cantor Fitzgerald Reiterates Overweight on Vera Therapeutics (VERA); Says Shares Undervalued

Aug 5, 2025 07:48AM Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c

Aug 4, 2025 06:11AM Wolfe Research Downgrades Vera Therapeutics (VERA) to Peerperform

Jun 9, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Vera Therapeutics (VERA)

Jun 6, 2025 09:45AM JPMorgan Defending Vera Therapeutics (VERA): 'pre-market weakness is overdone'

Jun 6, 2025 08:43AM Raymond James on Vera Therapeutics (VERA): 'we don’t think this is a referendum on the overall efficacy of these drugs in IgAN'

Jun 6, 2025 08:17AM Guggenheim on Vera Therapeutics (VERA): 'we would be incremental buyers on any weakness'

Jun 6, 2025 08:15AM TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)

Jun 6, 2025 08:14AM Evercore ISI Reiterates Outperform Rating on Vera Therapeutics (VERA)

Jun 3, 2025 06:54AM Vera Therapeutics (VERA) PT Raised to $85 at H.C. Wainwright

Jun 3, 2025 05:52AM Vera Therapeutics Inc. (VERA) call put ratio 2.1 calls to 1 put with a focus on June calls and puts

Jun 3, 2025 05:43AM Increasing unusual option volume: NVTS CLBR ASTL UMAC SIG VERA FROG

Jun 2, 2025 09:58AM Increasing unusual call option volume: CLBR NVTS CERA UMAC TRVI CENX ETHA BOX ONDS RELY IBRX

Jun 2, 2025 08:52AM TD Cowen: 'We Expect Vera Therapeutics (VERA) Shares To Be Up Likely 50-75%'

Jun 2, 2025 08:25AM JPMorgan Reiterates Overweight Rating on Vera Therapeutics (VERA), Top Idea

Jun 2, 2025 07:09AM Evercore ISI Reiterates Outperform Rating on Vera Therapeutics (VERA)

Jun 2, 2025 06:31AM Vera Therapeutics Inc. (VERA) Reports Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial

May 29, 2025 07:59AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)

May 23, 2025 06:49AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)

May 6, 2025 04:26PM Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 8c

Apr 3, 2025 08:04AM Vera Therapeutics (VERA) Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN

Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald

Feb 27, 2025 07:29AM Vera Therapeutics (VERA) PT Raised to $61 at Guggenheim

Feb 26, 2025 08:25AM Vera Therapeutics Inc. (VERA) Reports Q4, Provides Business Update

Feb 18, 2025 12:19PM Evercore ISI on Vera Therapeutics (VERA): 'buying opportunity'

Feb 18, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)

Feb 14, 2025 11:12AM Vera Therapeutics Inc. (VERA) Weakness Tied to Rival Drug, Analyst Says

Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside

Oct 29, 2024 06:04AM Vera Therapeutics Inc. (VERA) Announces Proposed $300M Share Offering

Oct 7, 2024 08:22AM TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)

Oct 3, 2024 06:01AM Evercore ISI Reiterates Outperform Rating on Vera Therapeutics (VERA)

Oct 2, 2024 06:31AM Vera Therapeutics (VERA) Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases

Oct 2, 2024 06:30AM Vera Therapeutics Inc. (VERA) Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results

Sep 30, 2024 08:30AM JPMorgan refreshed its U.S. Analyst Focus List, adding these six stocks

Sep 25, 2024 11:00AM JPM just refreshed its US Analyst Focus List, adding these 5 stocks

Sep 17, 2024 02:00PM JPMorgan refreshed its U.S. Analyst Focus List and added these four names

Sep 3, 2024 05:09AM Vera Therapeutics (VERA) PT Raised to $72 at JPMorgan, Added to AFL

Aug 8, 2024 09:21AM Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 6c

Jul 1, 2024 08:01AM Vera Therapeutics (VERA) Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer

Jun 11, 2024 04:01PM Vera Therapeutics (VERA) Appoints Christy J. Oliger to Board of Directors

View Older Stories